LI
ACAD icon

LRI Investments’s Acadia Pharmaceuticals ACAD Stock Holding History

LRI Investments’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$278 Sell
11
-124
-92% -$2.73K ﹤0.01% 1670
2026
Q1 		$3K Sell
135
-228
-63% -$5.45K ﹤0.01% 1203
2025
Q4 		$9.7K Buy
363
+135
+59% +$3.23K ﹤0.01% 874
2025
Q3 		$4.87K Buy
+228
New +$5.39K ﹤0.01% 1059
2025
Q2 		– Sell
-276
Closed -$4.58K – 1266
2025
Q1 		$4.58K Buy
+276
New +$5.01K ﹤0.01% 968

Other funds holding ACAD

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $5.7B AUM 35.76% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

LRI Investments's ACAD Position: Q2 2026 in Review

LRI Investments reduced its Acadia Pharmaceuticals (ACAD) stake by 92% in Q2 2026, selling an estimated $2.73K and leaving 11 shares worth $278. The position accounts for ﹤0.01% of the portfolio, ranked #1670.

LRI Investments first reported a position in ACAD in Q1 2025 and has held it in 5 quarters since. The position peaked at $9.7K in Q4 2025. 36 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • LRI Investments held 11 shares of Acadia Pharmaceuticals worth $278 as of Q2 2026.
  • LRI Investments sold 124 Acadia Pharmaceuticals shares in Q2 2026, an estimated $2.73K.
  • Acadia Pharmaceuticals made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1670 holding.
  • LRI Investments first reported a position in Acadia Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • LRI Investments's Acadia Pharmaceuticals position peaked at $9.7K in Q4 2025.
  • 36 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.